2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hodgkin Disease
50
Lymphoma
45
Testicular Neoplasms
13
Teratoma
12
HIV Infections
12
Acquired Immunodeficiency Syndrome
11
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, Non-Hodgkin
9
Head and Neck Neoplasms
8
Endodermal Sinus Tumor
8
Testicular Germ Cell Tumor
7
Sarcoma, Kaposi
7
Neoplasms
7
Carcinoma, Embryonal
7
Seminoma
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Follicular
6
Ovarian Neoplasms
5
Ovarian Germ Cell Cancer
5
Recurrence
4
Neoplasms, Germ Cell and Embryonal
4
Neoplasm Metastasis
4
Carcinoma, Squamous Cell
4
Vulvar Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Breast Neoplasms
3
Teratoma, Testicular
2
Skin Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Drug-Related Side Effects and Adverse Reactions
2
Interventions
pembrolizumab
2
Pemetrexed
2
nilotinib
1
glutathione pegylated liposomal doxorubicin
1
ficlatuzumab
1
Zoledronic Acid
1
Trastuzumab
1
Radiosurgery
1
MRX-2843
1
Everolimus
1
Electrochemotherapy
1
Denosumab
1
Cisplatin
1
Carboplatin
1
Bleomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplastic Processes
×
Bleomycin
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled